A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors (Q44613149)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 15, 2003
edit
Language Label Description Also known as
English
A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors
scientific article published on October 15, 2003

    Statements

    A phase I study of irinotecan as a 3-week schedule in children with refractory or recurrent solid tumors (English)
    A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit